Pharmaceutical Technology | Drug Development News & Views …
WEBPharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
Magazine: Cell and gene therapy approvals drive paradigm …
WEB11 hours ago · The growing global demand for cell and gene therapies (CGTs) is resulting in a manufacturing paradigm shift, reflecting the need to overcome a range of evolving new challenges and adapt to maintain rigorous safety and efficacy standards. This month’s cover story looks at how the acceleration in ...
Artificial Intelligence in Pharma: Innovations, Patents, and Trends
WEBAug 20, 2024 · Pharmaceutical companies are increasingly harnessing artificial intelligence (AI) to advance research and development, resulting in groundbreaking healthcare solutions. Recent innovations include AI-driven cancer treatment target identification, optimized drug combinations, and automated systems …
“Strategic market positioning” needed for Ebglyss to rival …
WEB15 hours ago · The atopic dermatitis US market size was estimated to be worth $7.1bn in 2023. Image credit: Shutterstock/ Katarzyna Hurova. Eli Lilly’s Ebglyss (lebrikizumab) will require strategic market positioning to differentiate it against more established atopic dermatitis treatments, though it is still ...
Pharmaceutical Technology’s most-read stories of 2023
WEBDec 19, 2023 · As the year comes to a close, we at Pharmaceutical Technology take stock at some of the biggest headlines of the year. One of the most popular stories on the site was a forward-looking feature that outlined the biggest expected catalysts involving CRISPR gene therapies and posited 2023 as the milestone year for this approach. The interest in this cutting edge technology was unsurprising given ...
Pharma breakthroughs: 10 novel drug approvals that made …
WEBDec 20, 2023 · Around 10 million people worldwide will die from cancer every year and approximately 685,000 of those deaths will be due to breast cancer. Orerdu (elacestrant) is a selective oestrogen receptor degrader (SERD) marketed by Stemline Therapeutics – a subsidiary of Menarini in the U.S.
Era of ADCs: Pharma companies innovate to stand out in a …
WEBAug 12, 2024 · Since 2023, ADCs have dominated the highest-value pharmaceutical deals with companies such as MSD and Daiichi Sankyo spending billions of dollars to expand their ADC pipelines. Aside from investments from pharmaceutical giants such as AstraZeneca and Bristol Myers Squibb, smaller biotechs are also finding purchase in the space as innovation stirs.
Unveiling the Top Pharmaceutical Companies Shaping the Industry
WEBThe world’s biggest pharmaceutical companies: Top ten by revenue. From Johnson & Johnson to Bristol Myers Squibb (BMS), Pharmaceutical Technology lists the top ten pharmaceutical companies in 2023, based on their revenues. Irena Maragkou. Top pharma companies in 2023. Image courtesy of Dmitry Kalinovsky/Shutterstock.
Pharma developments in 2022: what you need to know
WEBJan 5, 2022 · By GlobalData. The Covid-19 pandemic significantly altered the clinical trials landscape, and a Clinical Trials Arena analysis by Andrew and Kezia Parkins shows the frequency of decentralised clinical trials will reach new heights in 2022, with a 28% jump from last year. Looking at the bigger picture, Andrew reports that middle-income countries ...
How technology could transform drug research in 2022
WEBDec 14, 2021 · Pharmaceutical Technology takes a look at some of the tech innovations set to impact drug discovery and development in 2022. When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons. The ambitious and lesser-explored methods currently being applied in …